Dion Gisele 4
4 · Inhibikase Therapeutics, Inc. · Filed Sep 6, 2022
Insider Transaction Report
Form 4
Dion Gisele
Director
Transactions
- Award
Stock Option (right to buy)
2022-09-01+60,000→ 60,000 totalExercise: $0.95Exp: 2032-09-01→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option shares vest 50% on each of the first two anniversaries of September 1, 2022.